Unknown

Dataset Information

0

Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.

ABSTRACT:

SUBMITTER: Southern KW 

PROVIDER: S-EPMC6513216 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
| S-EPMC6353056 | biostudies-literature
Unknown Click-based synthesis of triazolobithiazole ?F508-CFTR correctors for cystic fibrosis.
| S-EPMC3419814 | biostudies-literature
Unknown Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).
| S-EPMC8094390 | biostudies-literature
Unknown Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.
| S-EPMC6464785 | biostudies-literature
Unknown Targeted therapies to improve CFTR function in cystic fibrosis.
| S-EPMC4582929 | biostudies-literature
Unknown Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors.
| S-EPMC6862496 | biostudies-literature
Unknown Nasal potential difference in cystic fibrosis considering severe CFTR mutations.
| S-EPMC4312569 | biostudies-literature
Unknown Towards next generation therapies for cystic fibrosis: Folding, function and pharmacology of CFTR.
| S-EPMC7052731 | biostudies-literature
Unknown Aberrant CFTR-dependent HCO3- transport in mutations associated with cystic fibrosis.
| S-EPMC3943212 | biostudies-literature
Unknown Novel CFTR Mutations in Two Iranian Families with Severe Cystic Fibrosis.
| S-EPMC4983674 | biostudies-literature